Table 2.

LNC characteristics: particle size, polydispersity, and zeta potential of blank and paclitaxel or DiI/DiD-loaded lipid nanocapsules, and drug payload of paclitaxel-loaded lipid nanocapsules

Batch name	Mean particle size (nm)	Polydispersity index	Zeta potential (mV)	Drug payload (mg/g)
Blank 55-LNC	55.9 ± 0.6	0.042 ± 0.007	−9.4 ± 0.8	–
25-LNC of Paclitaxel	27.0 ± 0.0	0.062 ± 0.007	−4.8 ± 0.5	1.79 ± 0.03
55-LNC of paclitaxel	54.7 ± 0.4	0.038 ± 0.008	−6.7 ± 1.1	1.86 ± 0.01
110-LNC of paclitaxel	118.3 ± 2.1	0.071 ± 0.016	−5.4 ± 0.4	1.27 ± 0.00
55-LNC of DiI/DiD	58.0 ± 2.1	0.166 ± 0.081	15.9 ± 1.8	–

Abbreviations: DiD, 1,1′-dioctadecyl-3,3,3′,3′-tetramethylindodicarbocyanine perchlorate; DiI, 1,1′-dioctadecyl-3,3,3′,3′-tetramethylindocarbocyanine perchlorate; LNC, lipid nanocapsules.